Top Markets
#1 Black Phoenix Black Phoenix +355.39%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.09%
#4 Akedo Akedo +49.04%
#5 Acurast Acurast +34.72%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.91%
#7 BasedHype BasedHype +25.74%
#8 Avantis Avantis +23.73%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Classificação em ações #40889
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Preço da ação
$0.0127
Última sincronização: 2026-08-12
Valor de mercado
$66.48K
Variação (1 dia)
-2.31%
Variação (1 ano)
-67.44%
País
US
Negociar Vincerx Pharma, Inc. (VINC)

Categoria

Healthcare
Histórico de preços das ações de Vincerx Pharma, Inc. (VINC)
Preço de fecho mais alto: $0.01 em 2026-08-01

Preço de fecho mais baixo: $195.93 em 2020-05-01
Histórico de preços das ações da Vincerx Pharma, Inc. de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $522.59 31.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.65 33.57%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE